Compare GWRE & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GWRE | HOLX |
|---|---|---|
| Founded | 2001 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical Electronics |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.3B | 16.6B |
| IPO Year | 2012 | 1990 |
| Metric | GWRE | HOLX |
|---|---|---|
| Price | $160.54 | $75.04 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 13 |
| Target Price | ★ $269.77 | $77.89 |
| AVG Volume (30 Days) | 1.3M | ★ 2.3M |
| Earning Date | 03-05-2026 | 01-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 191.31 | N/A |
| EPS | 1.06 | ★ 2.49 |
| Revenue | $1,272,197,000.00 | ★ $4,100,500,000.00 |
| Revenue This Year | $20.00 | $6.74 |
| Revenue Next Year | $15.45 | $5.53 |
| P/E Ratio | $150.87 | ★ $30.14 |
| Revenue Growth | ★ 22.80 | 1.74 |
| 52 Week Low | $154.51 | $51.90 |
| 52 Week High | $272.60 | $75.34 |
| Indicator | GWRE | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 28.29 | 57.04 |
| Support Level | $154.51 | $74.86 |
| Resistance Level | $160.85 | $75.31 |
| Average True Range (ATR) | 5.74 | 0.23 |
| MACD | -1.93 | -0.00 |
| Stochastic Oscillator | 16.41 | 66.10 |
Guidewire Software provides cloud-based software solutions for property and casualty insurers. The flagship product, InsuranceSuite is a system of record and comprises ClaimCenter, a claims management system; PolicyCenter, a policy management system including policy definitions, quotas, issuance, maintenance, and renewal; and BillingCenter, for billing management, payment plans, and agent commissions. The company also offers InsuranceNow, a midmarket offering, as well as a variety of other add-on applications and services.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.